Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Active TGF-β signaling and decreased expression of PTEN separates angiosarcoma of bone from its soft tissue counterpart.

Verbeke SL, Bertoni F, Bacchini P, Oosting J, Sciot R, Krenács T, Bovée JV.

Mod Pathol. 2013 Sep;26(9):1211-21. doi: 10.1038/modpathol.2013.56.

2.

Alterations of the p53 and PIK3CA/AKT/mTOR pathways in angiosarcomas: a pattern distinct from other sarcomas with complex genomics.

Italiano A, Chen CL, Thomas R, Breen M, Bonnet F, Sevenet N, Longy M, Maki RG, Coindre JM, Antonescu CR.

Cancer. 2012 Dec 1;118(23):5878-87. doi: 10.1002/cncr.27614.

3.

Involvement of the PI3K/Akt pathway in myxoid/round cell liposarcoma.

Demicco EG, Torres KE, Ghadimi MP, Colombo C, Bolshakov S, Hoffman A, Peng T, Bovée JV, Wang WL, Lev D, Lazar AJ.

Mod Pathol. 2012 Feb;25(2):212-21. doi: 10.1038/modpathol.2011.148.

4.

Angiosarcoma: a tissue microarray study with diagnostic implications.

Rao P, Lahat G, Arnold C, Gavino AC, Lahat S, Hornick JL, Lev D, Lazar AJ.

Am J Dermatopathol. 2013 Jun;35(4):432-7. doi: 10.1097/DAD.0b013e318271295a.

PMID:
23689692
5.

Epithelioid angiosarcoma of bone and soft tissue: a report of seven cases with emphasis on morphologic diversity, immunohistochemical features and clinical outcome.

Chen Y, Shen D, Sun K, Bao D, Song Q, Wang G, Chen D, Yan T, Guo W.

Tumori. 2011 Sep-Oct;97(5):585-9. doi: 10.1700/989.10716.

6.

Expression of angiopoietin-TIE system components in angiosarcoma.

Buehler D, Rush P, Hasenstein JR, Rice SR, Hafez GR, Longley BJ, Kozak KR.

Mod Pathol. 2013 Aug;26(8):1032-40. doi: 10.1038/modpathol.2013.43.

7.

Oral and salivary gland angiosarcoma: a clinicopathologic study of 29 cases.

Fanburg-Smith JC, Furlong MA, Childers EL.

Mod Pathol. 2003 Mar;16(3):263-71.

8.

Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.

Huang SC, Zhang L, Sung YS, Chen CL, Kao YC, Agaram NP, Singer S, Tap WD, D'Angelo S, Antonescu CR.

Am J Surg Pathol. 2016 May;40(5):645-55. doi: 10.1097/PAS.0000000000000582.

PMID:
26735859
9.

PIK3CA, BRAF, and PTEN status and benefit from cetuximab in the treatment of advanced colorectal cancer--results from NCIC CTG/AGITG CO.17.

Karapetis CS, Jonker D, Daneshmand M, Hanson JE, O'Callaghan CJ, Marginean C, Zalcberg JR, Simes J, Moore MJ, Tebbutt NC, Price TJ, Shapiro JD, Pavlakis N, Gibbs P, Van Hazel GA, Lee U, Haq R, Virk S, Tu D, Lorimer IA; NCIC Clinical Trials Group and the Australasian Gastro-Intestinal Trials Group..

Clin Cancer Res. 2014 Feb 1;20(3):744-53. doi: 10.1158/1078-0432.CCR-13-0606.

10.

PIK3CA alterations in Middle Eastern ovarian cancers.

Abubaker J, Bavi P, Al-Haqawi W, Jehan Z, Munkarah A, Uddin S, Al-Kuraya KS.

Mol Cancer. 2009 Jul 28;8:51. doi: 10.1186/1476-4598-8-51.

11.

Distinct histological features characterize primary angiosarcoma of bone.

Verbeke SL, Bertoni F, Bacchini P, Sciot R, Fletcher CD, Kroon HM, Hogendoorn PC, Bovée JV.

Histopathology. 2011 Jan;58(2):254-64. doi: 10.1111/j.1365-2559.2011.03750.x.

PMID:
21323951
12.

Mutation of the PTEN gene in a human hepatic angiosarcoma.

Tate G, Suzuki T, Mitsuya T.

Cancer Genet Cytogenet. 2007 Oct 15;178(2):160-2.

PMID:
17954274
13.

PI3K pathway activation provides a novel therapeutic target for pediatric ependymoma and is an independent marker of progression-free survival.

Rogers HA, Mayne C, Chapman RJ, Kilday JP, Coyle B, Grundy RG.

Clin Cancer Res. 2013 Dec 1;19(23):6450-60. doi: 10.1158/1078-0432.CCR-13-0222.

14.

Angiosarcoma of soft tissue: a study of 80 cases.

Meis-Kindblom JM, Kindblom LG.

Am J Surg Pathol. 1998 Jun;22(6):683-97.

PMID:
9630175
15.

Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas.

Liau JY, Tsai JH, Yang CY, Lee JC, Liang CW, Hsu HH, Jeng YM.

Hum Pathol. 2015 Sep;46(9):1360-6. doi: 10.1016/j.humpath.2015.05.019.

PMID:
26190196
16.

Expression status and mutational analysis of the PTEN and P13K subunit genes in ovarian granulosa cell tumors.

Bittinger S, Alexiadis M, Fuller PJ.

Int J Gynecol Cancer. 2009 Apr;19(3):339-42. doi: 10.1111/IGC.0b013e3181a1cdfd.

PMID:
19407556
17.

Frequent mono-allelic loss associated with deficient PTEN expression in imatinib-resistant gastrointestinal stromal tumors.

Quattrone A, Wozniak A, Dewaele B, Floris G, Vanspauwen V, Van Looy T, Schöffski P, Rutkowski P, Sciot R, Debiec-Rychter M.

Mod Pathol. 2014 Nov;27(11):1510-20. doi: 10.1038/modpathol.2014.53.

18.

Divergence of P53, PTEN, PI3K, Akt and mTOR expression in tonsillar cancer.

Chun SH, Jung CK, Won HS, Kang JH, Kim YS, Kim MS.

Head Neck. 2015 May;37(5):636-43. doi: 10.1002/hed.23643.

PMID:
24616007
20.

Supplemental Content

Support Center